Apr. 1, 2021IR News
Mar. 9, 2021News Release
Jan. 29, 2021IR News
J-TEC will be a company that will continue to grow and evolve as long as the human race exists. We will develop a new industry in the field of regenerative medicine, which will transform 21st century medical care, and we hold the philosophy that all stakeholders will achieve a better life as a result.
Basic IR guidelines
J-TEC continues to make timely and fair disclosures of information in compliance with laws and ordinances. We also continue to proactively disclose information that contributes to improvement of the transparency of our management. We value interactive communication.
We aim to make our IR activities plainly understandable by offering clear and comprehensible explanations and trying to put ourselves in the perspective of the shareholders. We strive to ensure that our IR activities reflect changes in the management environment and the needs of all of our shareholders and investors.
IR as a concerted effort
We practice systematic IR in which all executives and staff, centered on top management, bear responsibility to improve corporate value.
This website contains forward-looking statements such as company plans, forecasts, strategies and convictions. These statements are judgments made by our management on the basis of currently available information. Because these forward-looking statements are subject to significant uncertainties, actual results may differ materially from those presented.
We may change or remove information on this site at any time without notice. Links to third party pages are provided for convenience only. We disclaim any liability for all third party information and the use of it.
While we are taking the greatest possible precautions to include accurate and up-to-date information on this website, we disclaim all liability for any losses (including lost profits, loss of privacy, or loss or damage to data) resulting from errors in data or technical problems associated with this website.